Patent · US Active

Assays for nuclear hormone receptor binding

US8865421B2 · kind B2 · utility

0Cited by
5References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2009
Grant dateOct 21, 2014
Priority date
Expiry dateSep 6, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and genetic constructs are provided for detecting the binding of nuclear hormone receptors to a coactivator/corepressor. The methods employ enzyme fragment complementation using fragments of β-galactosidase as the detection system. Cells are transformed to express the large fragment of β-galactosidase fused to a member of the complex with NHR for initiation of transcription and have it localized in the nucleus and to express the small fragment of β-galactosidase fused to the nuclear hormone receptor for binding to the member upon stimulation with a ligand.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.